No Data
No Data
SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference
SeaStar Medical Strengthens Financial Position With Elimination of All Long-Term Debt
Express News | SeaStar Medical - Entered Into at Offering Agreement Relating to Sale of Common Stock Offered by Prospectus Supplement
Express News | SeaStar Medical Holding - May Offer, Sell Shares of Common Stock of up to $25 Mln From Time to Time
Buy Rating Affirmed for SeaStar Medical on Strong Pediatric Milestone and AKI Market Opportunity
Maxim Group Maintains SeaStar Medical(ICU.US) With Buy Rating, Announces Target Price $18
Maxim Group analyst Anthony Vendetti maintains $SeaStar Medical(ICU.US)$ with a buy rating, and sets the target price at $18.According to TipRanks data, the analyst has a success rate of 27.7% and a
No Data